MMP9 and breast cancer: Increased METTL14 and ALKBH5 levels were detected in hypoxia-treated breast cancer cells, which led to upregulation of angiogenic transcripts, including TGF-β, matrix metallopeptidase 9 (MMP9), PDGF, and VEGFA.